You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 10, October 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (67)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Biochemical Abnormalities in Vitreous of Humans With Proliferative Diabetic Retinopathy

J. Sebag, MD; Bruce Buckingham, MD; M. Arthur Charles, MD, PhD; Karen Reiser, MD

Arch Ophthalmol. 1992;110(10):1472-1476.


Abstract

• Vitreous changes in diabetes can exacerbate proliferative diabetic retinopathy. These changes may be due to the effects of diabetes on vitreous collagen. Vitreous samples from 19 patients with proliferative diabetic retinopathy and 23 patients without diabetes were analyzed for collagen crosslinks, as well as for the early glycation products, glucitolyllysine and glucitolylhydroxylysine. Fluorometry was performed to measure advanced glycation end products. Vitreous collagen derived from diabetic patients was found to have significantly higher levels of the crosslink dihydroxylysinonorleucine (3.15 vs 1.24 mol/mol collagen, P<.01) than that of control subjects. Early glycation products were elevated in diabetic vitreous (1.65 vs 0.54 mol/mol collagen, P<.05). Levels of advanced glycation end products were 20 times higher in diabetic vitreous compared with the vitreous of controls. These diabetes-induced alterations of human vitreous may be of particular importance given the role of vitreous in proliferative diabetic retinopathy and vision loss.



Author Affiliations

From the Doheny Eye Institute, University of Southern California, Los Angeles (Dr Sebag); the Schepens Eye Research Institute of Retina Foundation, Harvard Medical School, Boston, Mass (Dr Sebag); Diabetes Research Program, University of California, Irvine (Drs Buckingham and Charles); and the Department of Medicine, University of California, Davis (Dr Reiser).


Footnotes

Accepted for publication January 24, 1992.

Presented in part at the Association for Research and Vision in Ophthalmology, April 30,1990, and May 3, 1991, Sarasota, Fla; and the International Diabetes Federation, June 28, 1991, Washington, DC.

Reprint requests to 11th Floor, 18800 Delaware St, Huntington Beach, CA 92648 (Dr Sebag).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Amelioration of Diabetes-Associated Abnormalities in the Vitreous Fluid by an Inhibitor of Albumin Glycation
Cohen et al.
IOVS 2008;49:5089-5093.
ABSTRACT | FULL TEXT  

Signaling Pathways for Glycated Human Serum Albumin-Induced IL-8 and MCP-1 Secretion in Human RPE Cells
Bian et al.
IOVS 2001;42:1660-1668.
ABSTRACT | FULL TEXT  

Advanced glycation: an important pathological event in diabetic and age related ocular disease
STITT
Br J Ophthalmol 2001;85:746-753.
FULL TEXT  

Vitreopapillary traction in proliferative diabetic vitreoretinopathy
Kroll et al.
Br J Ophthalmol 1999;83:261-264.
ABSTRACT | FULL TEXT  

Variations of posterior vitreous detachment
Kakehashi et al.
Br J Ophthalmol 1997;81:527-532.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.